142 related articles for article (PubMed ID: 34522443)
1. Mitofusin-2 Promotes the Epithelial-Mesenchymal Transition-Induced Cervical Cancer Progression.
Ahn SY; Song J; Kim YC; Kim MH; Hyun YM
Immune Netw; 2021 Aug; 21(4):e30. PubMed ID: 34522443
[TBL] [Abstract][Full Text] [Related]
2. Mitofusin-2 enhances cervical cancer progression through Wnt/β-catenin signaling.
Ahn SY
BMB Rep; 2024 Apr; 57(4):194-199. PubMed ID: 38449303
[TBL] [Abstract][Full Text] [Related]
3. Mitofusin-2 Triggers Cervical Carcinoma Cell Hela Apoptosis via Mitochondrial Pathway in Mouse Model.
Wang W; Liu X; Guo X; Quan H
Cell Physiol Biochem; 2018; 46(1):69-81. PubMed ID: 29587277
[TBL] [Abstract][Full Text] [Related]
4. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
5. Mfn2 inhibits proliferation and cell-cycle in Hela cells via Ras-NF-κB signal pathway.
Liu X; Sun J; Yuan P; Shou K; Zhou Y; Gao W; She J; Hu J; Yang J; Yang J
Cancer Cell Int; 2019; 19():197. PubMed ID: 31384172
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
7. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
[No Abstract] [Full Text] [Related]
8. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
9. Regulatory effects of CCDC3 on proliferation, migration, invasion and EMT of human cervical cancer cells.
Zhang XF; An MZ; Ma YP; Lu YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3217-3224. PubMed ID: 31081073
[TBL] [Abstract][Full Text] [Related]
10. Circ-MFN2 Positively Regulates the Proliferation, Metastasis, and Radioresistance of Colorectal Cancer by Regulating the miR-574-3p/IGF1R Signaling Axis.
Liu D; Peng S; Li Y; Guo T
Front Genet; 2021; 12():671337. PubMed ID: 34093664
[TBL] [Abstract][Full Text] [Related]
11. Mitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt/β-catenin pathway.
Pang G; Xie Q; Yao J
Oncol Lett; 2019 Sep; 18(3):2434-2442. PubMed ID: 31402945
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
13. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
An HT; Yoo S; Ko J
Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
[TBL] [Abstract][Full Text] [Related]
14. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of RhoE Expression Enhances TGF-β-Induced EMT (epithelial-to-mesenchymal transition) in Cervical Cancer HeLa Cells.
Nishizuka M; Komada R; Imagawa M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546735
[TBL] [Abstract][Full Text] [Related]
16. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
[No Abstract] [Full Text] [Related]
17. MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.
Xu K; Chen G; Li X; Wu X; Chang Z; Xu J; Zhu Y; Yin P; Liang X; Dong L
Sci Rep; 2017 Feb; 7():41718. PubMed ID: 28176801
[TBL] [Abstract][Full Text] [Related]
18. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer.
Zhang L; Yao HR; Liu SK; Song LL
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2928-2937. PubMed ID: 32271410
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia and TGF-β1 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formation.
Xu F; Zhang J; Hu G; Liu L; Liang W
Cancer Cell Int; 2017; 17():54. PubMed ID: 28507454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
